Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of the Spanish electronic version of the BREAST-Q questionnaire.
Martínez-Pérez JL, Pascual-Dapena A, Pardo Y, Ferrer M, Pont À, López MJ, Nicolau P, Jiménez M, Masó P, Vernet-Tomás M, Argudo N. Martínez-Pérez JL, et al. Among authors: vernet tomas m. Eur J Surg Oncol. 2023 Aug;49(8):1417-1422. doi: 10.1016/j.ejso.2023.04.011. Epub 2023 Apr 21. Eur J Surg Oncol. 2023. PMID: 37179146
Accuracy of sentinel node mapping in patients with biopsy-proven metastatic axillary lymph nodes and upfront surgery: preliminary results of the Multimodal Targeted Axillary Surgery (MUTAS) trial.
Vernet-Tomás M, Argudo N, Jimenez M, Masó P, De Miguel M, Martínez A, Vidal-Sicart S, Aguilar Y, Rubio L, Valhondo R, Alcantara R, Arenas N, Pitarch M, de Las Heras IV, Comerma L, Sanz J, Algara M, Noguera A, Nicolau P. Vernet-Tomás M, et al. Gland Surg. 2023 Feb 28;12(2):140-151. doi: 10.21037/gs-22-480. Epub 2023 Feb 2. Gland Surg. 2023. PMID: 36915822 Free PMC article.
Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study.
Dave RV, Elsberger B, Taxiarchi VP, Gandhi A, Kirwan CC, Kim B, Camacho EM, Coles CE, Copson E, Courtney A, Horgan K, Fairbrother P, Holcombe C, Kirkham JJ, Leff DR, McIntosh SA, O'Connell R, Pardo R, Potter S, Rattay T, Sharma N, Vidya R, Cutress RI; B-MaP-C study collaborative. Dave RV, et al. Breast Cancer Res Treat. 2023 Jun;199(2):265-279. doi: 10.1007/s10549-023-06893-4. Epub 2023 Apr 3. Breast Cancer Res Treat. 2023. PMID: 37010651 Free PMC article.
Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
Posso M, Alcántara R, Vázquez I, Comerma L, Baré M, Louro J, Quintana MJ, Román M, Marcos-Gragera R, Vernet-Tomas M, Saladie F, Vidal C, Bargalló X, Peñalva L, Sala M, Castells X; BELE study group. Posso M, et al. Among authors: vernet tomas m. Eur Radiol. 2022 Jan;32(1):621-629. doi: 10.1007/s00330-021-08118-y. Epub 2021 Jun 22. Eur Radiol. 2022. PMID: 34156554
Assessing variability in breast cancer management across the world: results of a questionnaire survey amongst global international experts in breast cancer management.
Thekkinkattil D, Vidya R, Kwong A, Alajmi AA, Mutebi M, Gulluoglu B, Deo S, Fukuma E, Elder E, Gonzalez E, Warnberg F, Buccimazza I, Ung O, Walker M, Vernet-Tomas M, Peeters MTV, Johnson N, Paulinelli RR, Kuehn T, Veronesi P, Sarkar D, Dietz J. Thekkinkattil D, et al. Among authors: vernet tomas m. Ecancermedicalscience. 2022 Sep 2;16:1443. doi: 10.3332/ecancer.2022.1443. eCollection 2022. Ecancermedicalscience. 2022. PMID: 36405941 Free PMC article.
Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall.
Vernet-Tomás M, Louro J, Román M, Saladié F, Posso M, Prieto M, Vázquez I, Baré M, Peñalva L, Vidal C, Bargalló X, Sánchez M, Ferrer J, A Espinàs J, Quintana MJ, Rodríguez-Arana A, Castells X; BELE study group. Vernet-Tomás M, et al. Maturitas. 2021 Feb;144:53-59. doi: 10.1016/j.maturitas.2020.10.024. Epub 2020 Nov 4. Maturitas. 2021. PMID: 33358209
20 results